Lysteda
IUD May Be Best for Heavy Menstrual Bleeding »
"Jan. 9, 2013 -- Heavy menstrual bleeding is a rarely discussed but remarkably common condition that affects about 1 in 4 women.
For many, monthly periods are much more than a minor annoyance. They stop life in its tracks for days each"...
Read the IUD May Be Best for Heavy Menstrual Bleeding article »
Lysteda
INDICATIONS
LYSTEDA™ (tranexamic acid) tablets is indicated for the treatment of cyclic heavy menstrual bleeding [see Clinical Studies].
Prior to prescribing LYSTEDA (tranexamic acid tablets) , exclude endometrial pathology that can be associated with heavy menstrual bleeding.
DOSAGE AND ADMINISTRATION
Recommended Dosage
The recommended dose of LYSTEDA (tranexamic acid tablets) for women with normal renal function is two 650 mg tablets taken three times daily (3900 mg/day) for a maximum of 5 days during monthly menstruation. LYSTEDA (tranexamic acid tablets) may be administered without regard to meals. Tablets should be swallowed whole and not chewed or broken apart.
Renal Impairment
In patients with renal impairment, the plasma concentration of tranexamic acid increased as serum creatinine concentration increased [see CLINICAL PHARMACOLOGY]. Dosage adjustment is needed in patients with serum creatinine concentration higher than 1.4 mg/dL (Table 1).
Table 1: Dosage of LYSTEDA (tranexamic acid tablets) in Patients with Renal Impairment
| LYSTEDA | ||
| Serum Creatinine (mg/dL) | Adjusted Dose | Total Daily Dose |
| Cr above 1.4 and ≤ 2.8 | 1300 mg (two 650 mg tablets) two times a day for a maximum of 5 days during menstruation | 2600 mg |
| Cr above 2.8 and ≤ 5.7 | 1300 mg (two 650 mg tablets) once a day for a maximum of 5 days during menstruation | 1300 mg |
| Cr above 5.7 | 650 mg (one 650 mg tablet) once a day for a maximum of 5 days during menstruation | 650 mg |
HOW SUPPLIED
Dosage Forms And Strengths
650 mg tablets
Storage And Handling
LYSTEDA (tranexamic acid) tablets are provided as white oval-shaped tablets. Each tablet is debossed with the marking “XP650”and are supplied as:
| Quantity | Package Type | NDC Number |
| 30 tablets | HDPE bottle | 55566-2100-2 |
| 30 tablets | Carton containing 5 blister cards with 6 tablets per card | 55566-2100-6 |
| 100 tablets | HDPE bottle | 55566-2100-1 |
| 500 tablets | HDPE bottle | 55566-2100-5 |
Storage
Store at room temperature 25° C (77° F); excursions permitted to 15-30° C (59-86° F). [See USP Controlled Room Temperature].
Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054. By: Mikart, Inc. Atlanta, GA 30318. Rev. 4/2011
Last reviewed on RxList: 5/19/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Lysteda Information
Lysteda - User Reviews
Lysteda User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Lysteda sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
